Factor XII
| coagulation factor XII | |
|---|---|
| Identifiers | |
| Symbol | F12 |
| Entrez | 2161 |
| HUGO | 3530 |
| OMIM | 234000 |
| RefSeq | NM_000505 |
| UniProt | P00748 |
| Other data | |
| EC number | 3.4.21.38 |
| Locus | Chr. 5 q33-qter |
|
WikiDoc Resources for Factor XII |
|
Articles |
|---|
|
Most recent articles on Factor XII |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Factor XII at Clinical Trials.gov Clinical Trials on Factor XII at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Factor XII
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Factor XII Discussion groups on Factor XII Patient Handouts on Factor XII Directions to Hospitals Treating Factor XII Risk calculators and risk factors for Factor XII
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Factor XII |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hageman factor is a plasma protein now usually known as factor XII. It is an enzyme (EC 3.4.21.38) of the serine protease (or serine endopeptidase) class.
Function
It is part of the coagulation cascade and activates factor XI and prekallikrein.
Genetics
The gene for factor XII is located on the tip of the long arm of the fifth chromosome (5q33-qter).
Role in disease
Hageman factor deficiency is a rare hereditary disorder with a prevalence of about one in a million, although it is a little more common among Asians. Deficiency does not cause excessive hemorrhage as the other coagulation factors make up for the it. It may increase the risk of thrombosis, due to inadequate activation of the fibrinolytic pathway. The deficiency leads to activated partial thromboplastin times (PTT) greater than 200 seconds.
Two missense mutations have been identified in F12, the gene encoding human coagulation factor XII. These mutations are thought to be the cause of a very rare form of hereditary angioedema (HAE), called HAE type III.[1]
History
Hageman factor was first discovered in 1955 when a routine preoperative blood sample of the 37-year-old railroad brakeman John Hageman was found to have prolonged clotting time in test tubes, even though he had no hemorrhagic symptoms. Hageman was then examined by Dr. Oscar Ratnoff who found that Mr. Hageman lacked a previously unidentified clotting factor.[2] Dr. Ratnoff later found that the Hageman factor deficiency is autosomal recessive disorder, when examining several related people which had the deficiency. Paradoxically, pulmonary embolism contributed to Hageman's death after an occupational accident. Since then, case series clinical studies have identified an association of thrombosis and Factor XII deficiency, though the pathophysiology of the relationship is unclear.
References
- ↑ Cichon S, Martin L, Hennies HC; et al. (2006). "Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III". Am. J. Hum. Genet. 79 (6): 1098–104. doi:10.1086/509899. PMID 17186468.
- ↑ Ratnoff OD, Margolius A (1955). "Hageman trait: an asymptomatic disorder of blood coagulation". Trans. Assoc. Am. Physicians. 68: 149–54. PMID 13299324.
External links
- Factor+XII at the US National Library of Medicine Medical Subject Headings (MeSH)